CONCLUSIONS: Maximal resection significantly improves survival in glioblastoma patients aged ≥ 75 years, particularly those with MGMT-methylated tumors, and should be considered even in selected patients aged ≥ 80 years. Here, MGMT is linked to glioblastoma.